At a crossroad!
My liver biopsy last November came back that my cancer mutated from HER2 low to HER2+. I have started THP because of it.
I saw my MO yesterday who told me that my molecular study is not showing the HER2.
So I have 2 contradictory tests! She also said she presented my case to the molecular tumor board who unanimously recommended I stay on the current course of treatment until scans on March 5th.
The test will be when the Taxol is discontinued and whether the Herceptin/Perjeta is the right move or not..
Has anyone else ever dealt with something like this?
Thank you for listening 💕